Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells
Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells
نویسندگان: داود جعفری قراباغلو , یونس پیله ور سلطان احمدی , مهدی داداش پور , علی مطاع , نصرت اله ضرغامی
کلمات کلیدی: Keywords: Metformin, Phenformin, combination therapy
نشریه: 16525 , 11 , 21 , 2018
| نویسنده ثبت کننده مقاله |
نصرت اله ضرغامی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات هماتولوژی و انکولوژی |
| کد مقاله |
64027 |
| عنوان فارسی مقاله |
Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells |
| عنوان لاتین مقاله |
Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells |
| ناشر |
8 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: Breast cancer remains a global challenge, and further chemopreventive therapies are still immediately required. Emerging evidence has revealed the potent anti-cancer effects of biguanides, Metformin (MET) and Phenformin (PHE). Thus, To explore an efficient chemopreventive strategy for breast cancer, the antiproliferative effects of the combination of MET and PHE against breast cancer cells were assessed in this work.
Methods: Cytotoxic effects of the drugs individually and in combination against T47D and MDA-MB-231 breast cancer cells were assessed using MTT assay and the median-effect method was used to analyze the precise nature of the interaction between MET and PHE. Besides, the expression levels of hTERT after 48 h drug exposure was determined using qRT-PCR.
Results: Based on the cytotoxicity assay, both MET and PHE further inhibited the growth of MDA-MB-231 cells compared with T47D cells. It was found that MET+PHE drastically reduced the IC50 values of MET and PHE in both cells than the single treatments in synergistic manner. Importantly, MET and PHE in combination form showed higher antiproliferative effect with smaller IC50 values against MDA-MB-231 cells than T47D cells.
Real time PCR results revealed that hTERT expression was significantly reduced in both breast cancer cell lines treated with MET+PHE compared with the single treatments. In comparison between two types of breast cancer cells, it was detected that MET+PHE could further decline hTERT expression in MDA-MB-231cells than T47D cells (p<0.001).
Conclusion: It is speculated that the combination of MET and PHE may be a promising and convenient approach to improve the efficiency of breast cancer treatment. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 99999977777 77777 3.pdf | 1397/07/10 | 654430 | دانلود |